Research & Reviews: A Journal of Neuroscience

About the Journal

Research and Reviews: A Journal of Neuroscience [2277-6427(e)] is a peer-reviewed hybrid open access journal launched in 2011 and focused on the rapid publication of fundamental research papers on all areas of neurosciences. The scope of neuroscience has broadened to include different approaches …

View full focus & scope

Research & Reviews: A Journal of Neuroscience (RRJONS): 2277-6427(e) is a peer-reviewed hybrid open access journal launched in 2011 and focused on the rapid publication

View Full Focus & Scope

Journal Information

Title:

Research & Reviews: A Journal of Neuroscience

Abbreviation:

RRJONS

Issues Per Year:

3 Issues (Jan-April,May-August,Sept-Dec)

P-ISSN:

2277-6427

Publisher:

116314

DOI:

10.37591/RRJoNS

Starting Year:

2011

Subject:

Language:

English

Publication Format:

Hybrid Open Access

CC BY-NC-ND

Type:

Peer-reviewed Journal (Refereed Journal)

Address:

Editorial Board

View Full Editorial Board

rrjons maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Dr. Praveen Kumar Yadav, Consultant Neurologist

The Mission Hospital, West Bengal-, India,

Email :

Institutional Profile Link:

Journal: Research and Reviews: A Journal of Neuroscience

View Full Profile APID Profile

Latest Articles

A Dual-Model Deep Learning Framework for Early Alzheimer’s Detection Using Clinical Data and Neuroimaging with Architectural Performance Analysis

Author: Abha Jain, Sohan Lal Gupta, Megha Gupta, Mithlesh Arya, Veena Yadav

Alzheimer’s disease (AD) poses a significant global health challenge due to its increasing prevalence and the absence of definitive cures.

Autoencoder, clinical data analysis, convolutional neural network, deep learning, early detection, efficientnet, medical diagnostics, MRI brain imaging, neural network architecture, neuroimaging, transfer learning

23/02/2026 Published Regular Issue Subscription Review Article 1 - 12

Kisunla (Donanemab): A Novel Breakthrough Illuminating a Path to Better Alzheimer’s Outcomes

Author: Muchukota Sushma, Alena Reji Thomas, Jayashree S, Priya Singha, Payal Baral, Isbha Stephen, Shobha R. R. Hiremath

Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked by cognitive decline, memory loss, and loss of independence.

Alzheimer’s disease, amyloid-beta, disease-modifying therapy, Donanemab, Kisunla, monoclonal antibody

09/12/2025 Published Regular Issue Subscription Original Research 37 - 45

Alzheimer’s Disease Classification Based on Transfer Learning of New-CNN Model

Author: Aniket Malik, Prabhjot Kaur

The long-term, irreversible brain disorder “Alzheimer’s disease (AD)” currently has no known cure. Nonetheless, current medications may impede their advancement.

Alzheimer disease (AD), classification, convolutional neural network (CNN), detection, deep learning (DL), brain disease

09/12/2025 Published Regular Issue Subscription Review Article 16 - 23

A Review on Applications of Artificial Intelligence (AI) in Parkinsons’s Disease Diagnosis and Treatment and Its Future Challenges

Author: Gazal Rani

Parkinson’s disease (PD) is a long-term, progressive neurodegenerative disorder that mainly occurs in people older than 60 years, affecting nearly 1% of this population.

Parkinson’s disease (PD), neurodegenerative disorder, dopaminergic neurons, substantia nigra, motor symptoms, early diagnosis, therapeutic intervention, quality of life, artificial intelligence (AI)